Clearing Up Ozempic Vision Concerns

Quick Smiles:

• Studies show inconsistent signals and more research is underway.
• Semaglutide, the active ingredient in Ozempic and Wegovy, has the most data so far.
• Patients are advised to monitor vision and consult their doctor about any changes.

Lawsuits have been filed alleging Novo Nordisk failed to warn patients about NAION, a rare optic nerve injury, while the company maintains it is very uncommon.

Drug labels list possible vision changes and manufacturers say safety reviews are ongoing, so experts urge careful monitoring and further study.

“If a patient comes in and says, ‘I’ve been taking this drug for a year, but now I’m scared that I’m going to go blind because of it,’ what we tell them is, ‘Look, the substantial majority of patients who take these drugs won’t ever have vision problems,’”

“And we know that taking these drugs — if it allows you to lose weight, get your A1C better, get your blood pressure better — will have tremendous impact on your overall health and well-being.”

“For the vast majority of people, the benefits far exceed the risks of eye problems due to the use of these medications,”

“I’m not currently telling my patients to stop the medicines due to eye concerns.”

“This also relates to eye conditions, which are well-known comorbidities for people living with diabetes,”

“As part of our routine safety review process for tirzepatide, we have ongoing discussions with regulators regarding potential safety topics, and we will continue to review data, including any data regarding ophthalmic issues,”

If you take a GLP-1 medication, keep up with regular eye exams and speak with your clinician about any vision changes so you can safely enjoy the benefits.

Source